Cardiovascular safety of naltrexone and bupropion therapy: Systematic review and meta‐analyses
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiovascular safety of naltrexone and bupropion therapy: Systematic review and meta‐analyses
Authors
Keywords
-
Journal
Obesity Reviews
Volume 22, Issue 6, Pages -
Publisher
Wiley
Online
2021-04-13
DOI
10.1111/obr.13224
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Naltrexone–bupropion (Mysimba) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports
- (2020) Igho J. Onakpoya et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Network meta‐analysis of multicomponent interventions
- (2019) Gerta Rücker et al. BIOMETRICAL JOURNAL
- Benefits and Harms in Pivotal Trials of Oral Centrally Acting Antiobesity Medicines: A Systematic Review and Meta-Analysis
- (2018) Igho J. Onakpoya et al. Obesity
- Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain
- (2018) Lynn R. Webster et al. PAIN
- Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers
- (2018) Neal L. Benowitz et al. JAMA Internal Medicine
- Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity
- (2018) Sadiya S. Khan et al. JAMA Cardiology
- Genetics and epigenetics in obesity
- (2018) Kerstin Rohde et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Hypothalamic inflammation in obesity and metabolic disease
- (2017) Alexander Jais et al. JOURNAL OF CLINICAL INVESTIGATION
- From the past to future: from energy expenditure to energy intake to energy expenditure
- (2016) M J Müller et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors
- (2016) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events
- (2016) Rohan Khera et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Is 5% weight loss a satisfactory criterion to define clinically significant weight loss?
- (2015) Donald A. Williamson et al. Obesity
- Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
- (2013) P. Hollander et al. DIABETES CARE
- Bupropion for Smoking Cessation in Patients Hospitalized With Acute Myocardial Infarction
- (2013) Mark J. Eisenberg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)
- (2013) Caroline M. Apovian et al. Obesity
- Bariatric Surgery and Long-term Cardiovascular Events
- (2012) Lars Sjöström et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bupropion for Smoking Cessation in Patients With Acute Coronary Syndrome
- (2011) David Planer et al. ARCHIVES OF INTERNAL MEDICINE
- GRADE guidelines: 9. Rating up the quality of evidence
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- A Two-Year Randomized Trial of Obesity Treatment in Primary Care Practice
- (2011) Thomas A. Wadden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- (2010) W. Philip T. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative Effectiveness of 5 Smoking Cessation Pharmacotherapies in Primary Care Clinics
- (2009) Stevens S. Smith ARCHIVES OF INTERNAL MEDICINE
- Rational Design of a Combination Medication for the Treatment of Obesity
- (2008) Frank L. Greenway et al. Obesity
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search